Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 87-93

  Tewari, Krishnansu S ^a   Filiaci, Virginia L ^b   Spirtos, Nick M ^c   Mannel, Robert S ^d   Thigpen, J Tate ^e   Cibull, Michael L ^f   Monk, Bradley J ^g   Randall, Marcus E ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Buffalo Niagara Enterprise   (United States)

^c Women's Cancer Center of Nevada   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical stroma; Chemotherapy; Endometrial cancer; Radiotherapy; Single positive lymph node

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DATA EXTRACTION; ENDOMETRIUM CANCER; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTERINE CERVIX;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CERVIX UTERI; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS, PHASE III AS TOPIC; DOXORUBICIN; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PELVIS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84858334731     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.12.414     Document Type: Article

References (36)

1. R. Siegel, E. Ward, O. Brawley, and J. Jemal Ahmedin The impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. S.M. Ueda, D.S. Kapp, and M.K. Cheung Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths Am J Obstet Gynecol 198 218 2008 e1 e6
3. W.T. Creasman Revised FIGO staging for carcinoma of the endometrium Int J Gynaecol Obstet 2009 105 109
4. NCCN Practice Guidelines in Oncology - v.1.2010 www.nccn.org
5. M.E. Randall, V.I. Filiaci, and H. Muss Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 24 2006 36 44 (Pubitemid 46630491)
6. J.J. Mikuta International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988 Cancer 71 4 Suppl 1993 1460 1463 (Pubitemid 23056060)
7. D.R. Cox Regression model and life tables (with discussion) J R Stat Soc B 34 1972 187 219
8. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
9. L. Duchateau, and R. Sylvester Meta-analysis John Crowley, Handbook of statistics in clinical oncology 2001 Marcel Dekker, Inc. New York 525 543
10. S.T. Normand Tutorial in biostatistics meta-analysis: formulating, evaluating, combining, and reporting Stat Med 18 1999 321 359
11. M.E. Randall, and S. Reisinger Radiation therapy and combined chemo-irradiation in advanced and recurrent endometrial carcinoma Semin Oncol 1004 21 1994 91 99 (Pubitemid 24060845)
12. J.T. Thigpen, H.J. Buchsbaum, and C. Mangan Phase II trial of Adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Cancer Treat Rep 63 1979 21 27 (Pubitemid 9152662)
13. J.T. Thigpen, J.A. Blessing, and H. Homesley Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study Gynecol Oncol 33 1989 68 70 (Pubitemid 19106626)
14. J.T. Thigpen, J.A. Blessing, and P.J. DiSaia A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 12 1994 1408 1414 (Pubitemid 24206239)
15. J.T. Thigpen, M.F. Brady, and H.D. Homesley Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 22 2004 3902 3908 (Pubitemid 41079871)
16. M.S. Aapro, F.H. van Wijk, and G. Bolis Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group Ann Oncol 14 2003 441 448 (Pubitemid 36367423)
17. H.D. Homesley, V. Filiaci, and S.K. Gibbons A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study Gynecol Oncol 112 2009 543 552
18. Miller DS (study chair). GOG protocol 209: a randomized phase III trial of doxorubicin/cisplatin/paclitaxel and G-CSF versus carboplatin/paclitaxel in patients with stage III & IV or recurrent endometrial cancer. http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=305940&version= HealthProfessional&protocolsearchid=8603435
19. Matei D (study chair). GOG protocol 258: a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. http://www.cancer.gov/search/ViewClinicalTrials.aspx? cdrid=649079&version=HealthProfessional&protocolsearchid=7990461
20. H.D. Homesley, V. Filiaci, and S.K. Gibbons A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study Gynecol Oncol 112 2009 543 552
21. A.H. Klopp, A. Jhingran, and L. Ramondetta Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation Gynecol Oncol 115 2009 6 11
22. G. Nelson, M. Randall, and G. Sutton FIGO stage III endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant RT Gynecol Oncol 75 1999 211 214 (Pubitemid 29523020)
23. S. Gibbons, A. Martinez, and M. Schray Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma Int J Radiat Oncol Biol Phys 21 1991 1019 1025
24. R.S. Smith, D.S. Kap, and Q. Chen Treatment of high-risk uterine cancer with whole abdominopelvic RT Int J Radiat Oncol Biol Phys 48 2000 767 778
25. T. Onda, H. Yoshikawa, and K. Mizutani Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br J Cancer 5 1997 1836 1841 (Pubitemid 27230713)
26. C.V. Lutman, L.J. Havrilesky, and J.M. Cragun Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology Gynecol Oncol 102 2006 92 97 (Pubitemid 43870232)
27. N. Takeshima, K. Umayahara, and K. Fujiwara Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer Gynecol Oncol 102 2006 214 217 (Pubitemid 44041635)
28. R.E. Bristow, M.L. Zahurak, and C.J. Alexander FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival Int J Gynecol Cancer 13 2003 664 672 (Pubitemid 38222610)
29. L.J. Havrilesky, J.M. Cragun, and B. Calingaert Resection of lymph node metastases influences survival in stage IIIC endometrial cancer Gynecol Oncol 99 2005 689 695 (Pubitemid 41686554)
30. D.S. McMeekin, and T. Tillmanns Endometrial cancer: treatment of nodal metastases Curr Treat Options Oncol 4 2003 121 130
31. L.A. Katz, S.J. Andrews, and J. Fanning Survival after multimodality treatment for stage IIIC endometrial cancer Am J Obstet Gynecol 184 2001 1071 1073 (Pubitemid 32434246)
32. N. Umesaki, T. Tanaka, and M. Miyama Postoperative adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis: a pilot study Oncol Rep 7 2000 1083 1086
33. J.P. Orezzoli, S. Sioletic, and A. Olawaiye Stage II endometrioid adenocarcinoma of the endometrium. Clinical implications of cervical stromal invasion Gynecol Oncol 113 2009 316 323
34. S. Schmid, I.C. Hsu, and J.M. Hu Adjuvant radiation therapy in stage III node-positive uterine cancer Gynecol Oncol 115 2009 239 243
35. R. Ricciardi, and N. Baxter Association versus causation versus quality improvement: setting benchmarks for lymph node evaluation in colon cancer J Natl Cancer Inst 99 2007 414 415 (Pubitemid 47078734)
36. N.A. Rieger, F.S. Barnett, and J.W. Moore Quality of pathology reporting impacts on lymph node yield in colon cancer J Clin Oncol 25 2007 463 (Pubitemid 350003005)